Estimated prevalence of uncontrolled hypertension and multiple cardiovascular risk factors and their associated risk of coronary heart disease in the United States

Benner, Joshua S.; Smith, Timothy W.; Petrilla, Allison A.; Klingman, David; Goel, Sangeeta; Tang, Simon S.K.; Wong, Nathan D.

doi:10.1016/j.jash.2007.07.001

« Previous Next »Journal of the American Society of Hypertension
Volume 2, Issue 1 , Pages 44-53, January 2008

Estimated prevalence of uncontrolled hypertension and multiple cardiovascular risk factors and their associated risk of coronary heart disease in the United States

Joshua S. Benner, PharmD, ScD
- IMS Health, Inc., Arlington, Virginia, USA
- Drs. Benner, Smith, and Klingman are all employees of IMS Health, Inc, a health information services and consulting firm. They have provided consulting services to manufacturers of antihypertensive and lipid-lowering therapies, including Pfizer Inc., Schering-Plough Corporation, and AstraZeneca Pharmaceuticals LP.
- Corresponding author: Joshua S. Benner, PharmD, ScD, Principal, IMS Health, Inc., 300 N. Washington Street, Suite 303, Arlington, Virginia 22046. Tel: 703-286-2868; fax: 703-286-2899.
Timothy W. Smith, BA
- IMS Health, Inc., Arlington, Virginia, USA
- Drs. Benner, Smith, and Klingman are all employees of IMS Health, Inc, a health information services and consulting firm. They have provided consulting services to manufacturers of antihypertensive and lipid-lowering therapies, including Pfizer Inc., Schering-Plough Corporation, and AstraZeneca Pharmaceuticals LP.
Allison A. Petrilla, MPH
- IMS Health, Inc., Arlington, Virginia, USA
- Ms. Petrilla and Ms. Goel are consultants to IMS Health, Inc, and Ms. Petrilla is a former employee of IMS Health, Inc.
David Klingman, PhD
- IMS Health, Inc., Arlington, Virginia, USA
- Drs. Benner, Smith, and Klingman are all employees of IMS Health, Inc, a health information services and consulting firm. They have provided consulting services to manufacturers of antihypertensive and lipid-lowering therapies, including Pfizer Inc., Schering-Plough Corporation, and AstraZeneca Pharmaceuticals LP.
Sangeeta Goel, PharmD
- IMS Health, Inc., Arlington, Virginia, USA
- Ms. Petrilla and Ms. Goel are consultants to IMS Health, Inc, and Ms. Petrilla is a former employee of IMS Health, Inc.
Simon S.K. Tang, MPH
- Pfizer Inc., New York, New York, USA
- Mr. Tang is an employee of, and holds stock options for, Pfizer Inc.
Nathan D. Wong, PhD
- Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine, California, USA
- Dr. Wong receives grant support from Pfizer Inc., and Bristol Myers Squibb, and is on the speakers’ bureau for Pfizer Inc., Sanofi-Aventis, and Takeda. The staff of IMS Health were paid consultants to Pfizer Inc., in connection with the development of this article.